✦ LIBER ✦

Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?

✍ Scribed by Uramoto, H; Mitsudomi, T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor (EGFR)

✍ Yi, Hyeon Gyu; Kim, Hye Jin; Kim, Yu Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Ho 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A diagnostic algorithm using EGFR mutati

✍ Kawahara, Akihiko; Taira, Tomoki; Azuma, Koichi; Tominaga, Masaki; Hattori, Sato 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 641 KB

Continuous EGFR-TKI administration follo

✍ Shukuya, Takehito; Takahashi, Toshiaki; Naito, Tateaki; Kaira, Rieko; Ono, Akira 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 283 KB

A dramatic lung cancer course in a patie

✍ Demierre, Nadine; Zoete, Vincent; Michielin, Olivier; Stauffer, Edouard; Zimmerm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 512 KB

KRAS Mutation in Patients with Lung Canc

✍ Ji-lin Guan MD,Wen-zhao Zhong MD,She-juan An PhD… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 324 KB

The use of mutation-specific antibodies

✍ Zhao, Jingya; Wang, Xiaoying; Xue, Liang; Xu, Nuo; Ye, Xin; Zeng, Haiying; Lu, S 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 514 KB